JAMA JAMA is an international peer-reviewed general medical journal published weekly online and in print.

The official page for JAMA http://jama.com, an international, peer-reviewed journal published weekly online and in print.

09/04/2026

Medicaid and its sister program CHIP provide health insurance for half of US children. In all, Medicaid covers 74 million people, or about 1 in 5 Americans. In the latest episode of , health policy researcher Julie Donohue, PhD, explains the vital role Medicaid plays in the US, and the challenges ahead with massive cuts looming.

👂 Listen to learn more: https://ja.ma/4cu5RsB

In a  , a medical student describes how substantial   during medical training improved sleep apnea, exercise tolerance, ...
09/03/2026

In a , a medical student describes how substantial during medical training improved sleep apnea, exercise tolerance, and metabolic measures, yet was also associated with disorientation, grief, and a disrupted sense of self.

https://ja.ma/3Uyuuy8

  is a digestive disorder involving delayed emptying of the stomach that may cause nausea, vomiting, feeling full quickl...
09/03/2026

is a digestive disorder involving delayed emptying of the stomach that may cause nausea, vomiting, feeling full quickly, bloating, and upper abdominal pain or discomfort.

📄 This JAMA Patient Page describes common risk factors, including type 1 and type 2 , prior surgery, cannabis use, and medications that slow stomach emptying such as opioids, anticholinergics, and glucagon-like peptide-1 receptor agonists.

https://ja.ma/4gMGTWq

 :   provides health insurance for 1 in 5 US residents and supports care across the life course, including childhood cov...
09/03/2026

: provides health insurance for 1 in 5 US residents and supports care across the life course, including childhood coverage, pregnancy, disability, and long-term care.

🎙️ In this episode, JAMA Senior Editor Derek Angus, MD, MPH, spoke with Julie Donohue, PhD, professor and chair of health policy and management at the University of Pittsburgh and deputy editor at JAMA Health Forum, about how the One Big Beautiful Bill Act could reduce Medicaid spending by nearly $1 trillion by 2034 and affect patients, clinicians, hospitals, and communities.

🔗 Listen now: https://ja.ma/46DxH1Z

 , or death as determined by neurologic criteria, can be difficult for families to understand because patients may still...
09/02/2026

, or death as determined by neurologic criteria, can be difficult for families to understand because patients may still have a pulse, warm skin, chest rise with mechanical ventilation, or reflexive movements.

💡 This JAMA Insights article discusses how simple, direct, and precise language may help clinicians communicate that brain death is legal death and reduce confusion during evaluation and determination.

🔗 https://ja.ma/3V8Jump

💬 Editorial by JAMA+ Trials Editor in Chief Alison J. Huang, MD, MAS, Thomas G. Travison, PhD, and JAMA Senior Editor De...
09/02/2026

💬 Editorial by JAMA+ Trials Editor in Chief Alison J. Huang, MD, MAS, Thomas G. Travison, PhD, and JAMA Senior Editor Derek C. Angus, MD, MPH:

are intended to support real-world clinical decision-making, but the term is used inconsistently across studies. A pragmatic orientation may improve the applicability of to routine care, yet it does not justify weaker methods or reduced rigor.

📣 This September’s JAMA+ Trials Theme of the Month examines ongoing confusion and debate in pragmatic trial research, including how eligibility, intervention delivery, outcome assessment, and analysis align with pragmatic goals. Clearer design and reporting may help clinicians and health systems judge whether trial findings are usable in practice.

🔗 https://ja.ma/4gHsJHH

09/02/2026

Vaccination remains the most effective way to reduce severe illness, hospitalization, and death from , , and . New JAMA Special Communication articles offer timely, evidence-based reviews of effectiveness and safety to support informed decisions for the 2026–2027 respiratory virus season.

📖Learn more: https://ja.ma/4gK66Ro

Today, JAMA publishes three detailed evidence reviews on vaccinations for  ,  , and  . Based on the latest peer-reviewed...
09/02/2026

Today, JAMA publishes three detailed evidence reviews on vaccinations for , , and .

Based on the latest peer-reviewed literature and 2025-2026 data, these reviews form the basis of formal 2026-2027 immunization recommendations from American College of Obstetricians & Gynecologists - ACOG, American Academy of Pediatrics (AAP), American Academy of Family Physicians (AAFP), and the Infectious Diseases Society of America (IDSA).

Additionally, JAMA publishes an accompanying Perspective coauthored by leaders of American Medical Association and the Vaccine Integrity Project (Center for Infectious Disease Research and Policy (CIDRAP)).

🔗 Perspective by Sandra Adamson Fryhofer, MD, Andrea Garcia, JD, MPH, Michael Osterholm, PhD, MPH, and Rochelle Walensky, MD, MPH: https://ja.ma/4qN4CKQ

All articles are free to the public.
🔗 Evidence review for influenza: https://ja.ma/4xytloN
🔗 Evidence review for COVID-19: https://ja.ma/3UwDGmB
🔗 Evidence review for RSV: https://ja.ma/4wZKqXx

📌 Editor’s Choice from this week's issue of JAMA:➡️   to Reduce Acute   After    ➡️  ****ne E-Cigarettes for Cigarette  ...
09/01/2026

📌 Editor’s Choice from this week's issue of JAMA:

➡️ to Reduce Acute After
➡️ ****ne E-Cigarettes for Cigarette Cessation,
➡️ High-Dose in , and more.

https://ja.ma/4cjwuAn

Among patients with previously untreated metastatic  , adding high-dose vitamin D3 to standard chemotherapy plus bevaciz...
09/01/2026

Among patients with previously untreated metastatic , adding high-dose vitamin D3 to standard chemotherapy plus bevacizumab did not improve progression-free survival compared with standard-dose vitamin D3.

Objective response and overall survival were also similar between groups.

https://ja.ma/4629fHq

Address

330 N Wabash Avenue
Chicago, IL
60611

Telephone

+13126707827

Alerts

Be the first to know and let us send you an email when JAMA posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share